Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Division of Physiology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
Molecules. 2019 Jun 15;24(12):2243. doi: 10.3390/molecules24122243.
extract (BME) is an abundant source of bioactive compounds, including saponins and flavonoids known to produce vasodilation. However, it is unclear which components are the more effective vasodilators. The aim of this research was to investigate the vasorelaxant effects and mechanisms of action of saponins and flavonoids on rat isolated mesenteric arteries using the organ bath technique. The vasorelaxant mechanisms, including endothelial nitric oxide synthase (eNOS) pathway and calcium flux were examined. Saponins (bacoside A and bacopaside I), and flavonoids (luteolin and apigenin) at 0.1-100 µM caused vasorelaxation in a concentration-dependent manner. Luteolin and apigenin produced vasorelaxation in endothelial intact vessels with more efficacy (E 99.4 ± 0.7 and 95.3 ± 2.6%) and potency (EC 4.35 ± 1.31 and 8.93 ± 3.33 µM) than bacoside A and bacopaside I (E 83.6 ± 2.9 and 79.9 ± 8.2%; EC 10.8 ± 5.9 and 14.6 ± 5.4 µM). Pretreatment of endothelial intact rings, with L-NAME (100 µM); an eNOS inhibitor, or removal of the endothelium reduced the relaxant effects of all compounds. In K-depolarised vessels suspended in Ca-free solution, these active compounds inhibited CaCl-induced contraction in endothelial denuded arterial rings. Moreover, the active compounds attenuated transient contractions induced by 10 µM phenylephrine in Ca-free medium containing EGTA (1 mM). Thus, relaxant effects occurred in both endothelial intact and denuded vessels which signify actions through both endothelium and vascular smooth muscle cells. In conclusion, the flavonoids have about twice the potency of saponins as vasodilators. However, in the BME, there is ~20 × the amount of vaso-reactive saponins and thus are more effective.
BME 是生物活性化合物的丰富来源,包括皂甙和黄酮类化合物,已知它们能产生血管舒张作用。然而,目前尚不清楚哪些成分是更有效的血管舒张剂。本研究旨在采用器官浴技术研究皂甙和黄酮类化合物对大鼠离体肠系膜动脉的血管舒张作用及其作用机制。考察了血管舒张机制,包括内皮型一氧化氮合酶(eNOS)途径和钙流。0.1-100 μM 的皂甙(bacoside A 和 bacopaside I)和黄酮类化合物(木犀草素和芹菜素)以浓度依赖的方式引起血管舒张。木犀草素和芹菜素在有完整内皮的血管中产生更强的血管舒张作用(E 99.4 ± 0.7 和 95.3 ± 2.6%)和更高的效能(EC 4.35 ± 1.31 和 8.93 ± 3.33 μM),优于 bacoside A 和 bacopaside I(E 83.6 ± 2.9 和 79.9 ± 8.2%;EC 10.8 ± 5.9 和 14.6 ± 5.4 μM)。预先用 100 μM 的 L-NAME(一种 eNOS 抑制剂)处理完整内皮环或去除内皮,会降低所有化合物的舒张作用。在 Ca 2+ 缺失溶液中悬浮的 K + 去极化血管中,这些活性化合物抑制了内皮去极化动脉环中由 10 μM 苯肾上腺素引起的 CaCl 2 诱导的收缩。此外,在含有 1 mM EGTA 的 Ca 2+ 缺失的无钙介质中,这些活性化合物还可减弱由 10 μM 苯肾上腺素引起的短暂收缩。因此,在有完整内皮和去内皮的血管中均观察到舒张作用,这表明作用机制涉及内皮和血管平滑肌细胞。总之,黄酮类化合物作为血管舒张剂的效能约为皂甙的两倍。然而,在 BME 中,具有血管活性的皂甙含量约为其 20 倍,因此更为有效。